Epivax Oncology - Providence Business News

Home Tags Epivax Oncology

EPIVAX WILL celebrate its 20th anniversary in a new Olneyville office at 166 Valley St. June 15.

EpiVax moves growing staff to Olneyville

Health Services 06/11/2018

PROVIDENCE — Immunology engineering biotech firm EpiVax Inc. continues an eventful anniversary year with a new headquarters at 188 Valley St. in the Rising...

EPIVAX PRESIDENT AND CEO Dr. Anne S. De Groot. EpiVax has launched a venture-backed spinoff, Epivax Oncology. / PBN FILE PHOTO

EpiVax launches EpiVax Oncology for personalized cancer vaccines

Health Services 09/25/2017

PROVIDENCE — Immunolgy engineering biotech firm EpiVax Inc. has launched EpiVax Oncology Inc., a venture-backed spinoff focused on the development of personalized therapeutic cancer...

FAST SEQUENCING: Dr. Anne S. De Groot, EpiVax Inc. CEO and chief strategy officer, says the Providence company has spent the past 20 years developing immunoinformatics tools. EpiVax spinoff EpiVax Oncology will use those tools along with fast sequencing to design cancer vaccines specific to individual patients. / PBN PHOTO/MICHAEL SALERNO

Renowned vaccine researcher Dr. Anne S. De Groot is ready to...

Entrepreneurship 08/11/2017

In 1997, Dr. Anne S. De Groot founded EpiVax Inc. in Providence, backed by a Small Business Innovation Research grant from the National Institutes...

- Featured Event -

Latest News

SUE AND WILLIAM CONATY have made a $1 million gift to Bryant University to establish the Conaty Scholars Endowed Fund, the largest gift for endowed scholarships in the university’s history. / COURTESY BRYANT UNIVERSITY

Bryant University receives $1M gift to establish new endowed scholarship fund

10/11/2024

Discover Newport CEO Evan Smith announces retirement

10/11/2024

R.I. Commerce Corp. lands $1.6M for small businesses

10/11/2024

U.S. consumer sentiment slips in October on frustration over high prices

10/11/2024

SEC filing of the week: Equinor buys 10% stake in Orsted

10/11/2024

SUBSCRIBE TO

PBN's All Access Subscription

PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.